PerkinElmer
This article was originally published in The Gray Sheet
Executive Summary
Neonatal screening kits produced at the firm's Norton, Ohio plant are subject to additional FDA testing and labeling requirements, per a Feb. 13 agreement with the agency allowing the resumption of production. The plant is slated to shut in approximately six months, with all manufacturing to be consolidated at a Turku, Finland site. U.S. marshals seized nearly $1 mil. in kits Feb. 4, due to a lack of response to QSR violations (1"The Gray Sheet" Feb. 9, 2004, p. 16)...
You may also be interested in...
PerkinElmer Neonatal IVD Seizure Attributed To Poor Documentation
Recent staff turnover at PerkinElmer's Norton, Ohio manufacturing site partly accounted for a failure to address QSR violations that prompted seizure of neonatal screening kits, according to the firm
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.